---
layout: post
title: "Berger Montague PC Investigating Claims on Behalf of Investors in Ultragenyx Pharmaceutical Inc. After Class Action Filing (NASDAQ: RARE)"
date: 2026-02-06T16:41:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/berger-montague-pc-investigating-claims-on-behalf-of-investors-in-ultragenyx-pharmaceutical-inc-after-class-action-filing-nasdaq-rare-302681400.html
significance: 8.00
---

<p>PHILADELPHIA, Feb. 6, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) ("Ultragenyx" or the "Company") on behalf of investors who purchased Ultragenyx common...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/berger-montague-pc-investigating-claims-on-behalf-of-investors-in-ultragenyx-pharmaceutical-inc-after-class-action-filing-nasdaq-rare-302681400.html)

**Published:** 2026-02-06 16:41:00 +0000

**Significance Score:** 8.00

[View original](https://www.prnewswire.com/news-releases/berger-montague-pc-investigating-claims-on-behalf-of-investors-in-ultragenyx-pharmaceutical-inc-after-class-action-filing-nasdaq-rare-302681400.html)
